Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Cancer J. 2016 Jan-Feb;22(1):27–33. doi: 10.1097/PPO.0000000000000166

Figure 2.

Figure 2

CAR T cell production and use. Peripheral blood mononuclear cells (PBMCs) are collected from the patient via apheresis and stimulated PMBCs are exposed to the viral or non-viral vector. T cells are stimulated using anti-CD3/anti-CD28 monoclonal antibody-coated magnetic beads with or without additional exogenous cytokines. Patients then receive lymphodepleting chemotherapy followed by infusion of CAR T cells.